Registry for patients with left ventricular thrombus
Observational Registry to Determine the Predictors and Outcomes of Patients at Risk of and Diagnosed With Left Ventricular Thrombus
This study is gathering information from people with blood clots in the heart to better understand the condition and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Queen Mary University of London Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT06963567 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on patients with left ventricular thrombus (LVT), a condition where blood clots form in the heart's main chamber, often following a heart attack or in cases of heart failure. By collecting information on patient demographics, clinical factors, and quality of life, the study seeks to enhance understanding of LVT formation and management. Participants will have their blood and scan results recorded, and may complete a quality of life questionnaire during routine MRI scans. The ultimate goal is to improve treatment strategies for LVT and reduce associated complications such as stroke.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with left ventricular thrombus or those at high risk for developing it due to severe left ventricular dysfunction or a history of myocardial infarction.
Not a fit: Patients under 18 years of age or those unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients at risk of or suffering from left ventricular thrombus.
How similar studies have performed: While there may be existing studies on left ventricular thrombus, this registry approach is aimed at enhancing understanding and management, making it a valuable addition to the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with LV thrombus or; * Patients at risk for developing LV thrombus (e.g severe LV dysfunction, LV aneurysm, MI. Exclusion Criteria: * Age \< 18 years * Unable to consent
Where this trial is running
London
- St Bartholomew's Hospital — London, United Kingdom (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.